| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |